# DIFLUPREDNATE

NDC: 69315-329
Generic name: DIFLUPREDNATE
Labeler / Manufacturer: Leading Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: EMULSION
Routes: OPHTHALMIC
Marketing started: 20250218

FDA application: ANDA219441

## Active ingredients

- DIFLUPREDNATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69315-329"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-329
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=054ca798-454a-41cc-9d08-97bb8bef5620